Overview

• The Pediatrics study randomized 30 practices caring for 18,480 infants across Chicago and Peoria, involving 290 clinicians.
• The intervention combined a short training video, EHR decision prompts, parent handouts, and an eczema severity scorecard.
• Guideline adherence rose to 84% versus 35% for low-risk infants and to 27% versus 10% for high-risk infants in intervention versus control clinics.
• Among high-risk infants, allergist referral or testing increased to 36% from 10%, though absolute adherence in this group remained modest.
• Investigators will follow children to age 2.5 years to assess effects on peanut allergy prevalence, and they highlight the approach’s scalability if outcomes are favorable.